مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

311
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

98
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A DRUG UTILIZATION EVALUATION STUDY OF AMPHOTERICIN B IN NEUTROPENIC PATIENTS IN A TEACHING HOSPITAL IN IRAN

Pages

  151-156

Keywords

DRUG UTILIZATION EVALUATION (DUE) 

Abstract

 Drug Utilization Evaluation (DUE) studies facilitate assessing the appropriateness and rational use of medications. The goal of the present study was to evaluate AMPHOTERICIN B usage in neutropenic patients. A prospective DUE study was performed in Hematology-Oncology and Stem Cell Transplantation wards at Taleghani hospital for one-year. National comprehensive cancer network, clinical practice guidelines in oncology, American Hospital Formulary Service and other relevant medical practice and up-to dated articles were used to evaluate whether AMPHOTERICIN B is properly used according to the guidelines. All data collected by a pharmacistin daily review using information of physician and nursing records as well as laboratory findings. During the one-year study, 35 patients receiving AMPHOTERICIN B were evaluated.29 patients (82.9%) received AMPHOTERICIN B due to neutropenia and fever and 6 patients had confirmed fungal infections. All of the injectable solutions of AMPHOTERICIN B were appropriately prepared for intravenous infusion. In addition, for all patients, ordering (indication) of the study drug was in accordance with the guidelines. Twenty-five (71.4%) patients received an appropriate dose according to the guidelines. Duration of treatment was properly selected in 21 (60%) patients. Twenty-two (62.8%) patients developed hypokalemia as the most frequent adverse drug event. Although, preparation and indication of AMPHOTERICIN B was in compliance with the current guidelines, dosage and duration of treatment were considered to be incoherent with the designed protocol used in this study. We conclude more attention should be paid to dosage and duration of treatment with AMPHOTERICIN B in order to optimize its administration.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    TAVAKOLI ARDAKANI, MARIA, ESHRAGHI, AZADEH, HAJHOSSEIN TALASAZ, AZITA, & SALAMZADEH, JAMSHID. (2012). A DRUG UTILIZATION EVALUATION STUDY OF AMPHOTERICIN B IN NEUTROPENIC PATIENTS IN A TEACHING HOSPITAL IN IRAN. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 11(1), 151-156. SID. https://sid.ir/paper/287901/en

    Vancouver: Copy

    TAVAKOLI ARDAKANI MARIA, ESHRAGHI AZADEH, HAJHOSSEIN TALASAZ AZITA, SALAMZADEH JAMSHID. A DRUG UTILIZATION EVALUATION STUDY OF AMPHOTERICIN B IN NEUTROPENIC PATIENTS IN A TEACHING HOSPITAL IN IRAN. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2012;11(1):151-156. Available from: https://sid.ir/paper/287901/en

    IEEE: Copy

    MARIA TAVAKOLI ARDAKANI, AZADEH ESHRAGHI, AZITA HAJHOSSEIN TALASAZ, and JAMSHID SALAMZADEH, “A DRUG UTILIZATION EVALUATION STUDY OF AMPHOTERICIN B IN NEUTROPENIC PATIENTS IN A TEACHING HOSPITAL IN IRAN,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 11, no. 1, pp. 151–156, 2012, [Online]. Available: https://sid.ir/paper/287901/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button